PET Scans Help Diagnose Alzheimer's Disease
PET/CT Imaging and Leqembi for Alzheimer's Disease with Dr. Robert Bridwell
Uses of Florbetapir PET Scans Set to Take Shape
The FDA Has Approved Aducanumab (Aduhelm™). Now What?
Safely Disclosing Amyloid Results with Alzheimer’s Disease Research Participants
Imaging’s Role in the Diagnosis of Alzheimer Disease
Amyloid Brain PET: Advancing Alzheimer's Disease Detection
Quantitative Imaging for Dementia - Case review with Dr. Bash
What To Know About the New Treatment for Alzheimer’s Disease w/ Elliot M. Sklar, PhD August 29 2023
Dementia Drugs Town Hall: What’s New, What’s Old, What’s Approved, What’s Covered
The movement favoring early diagnosis and treatment of Alzheimer’s disease is gaining momentum
Implications of Aducanumab, the New Alzheimer's Drug with Gil Rabinovici and Rita Redberg
Webinar: CMS's Coverage Decision: It's Not Just About Alzheimer's Disease
Alzheimer’s Disease and Dementia Advisory Council
Alzheimer's Disease 2021: Hot Topics in Disease Prevention and Clinical Trials
Syndrome-biomarker correlations in Alzheimer disease: Insights from ADNI and tau PET
Can we detect and treat Alzheimer's disease a decade before dementia? (And why we must!)
When It's Not Alzheimer's
The Case for Disclosing Biomarker Results to Alzheimer’s Research Participants
When, and When Not, to Use PET/CT Part 2
